| Date Filed | Type | Description |
| 07/03/2023 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 06/02/2023 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Malley Thomas (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 16,692 shares
@ $0
Granted 34,645 options to buy
@ $0 |
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 33,237 options to buy
@ $14.33, valued at
$476.3k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Malley Thomas (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 64,610 options to buy
@ $0 |
|
| 05/30/2019 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 18,760 options to buy
@ $15.47, valued at
$290.2k
|
|
| 06/08/2018 |
4
| Malley Thomas (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 9,290 shares
@ $0
Granted 17,442 options to buy
@ $0 |
|
| 06/08/2018 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 13,000 options to buy
@ $16.35, valued at
$212.6k
|
|
| 05/29/2018 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Converted 71,967 shares
@ $0
Converted 71,967 options to buy
@ $0 |
|
| 05/23/2018 |
3
| Malley Thomas (Director) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd. |
| 07/05/2017 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc.|
Txns:
| Granted 7,873 shares
@ $0 |
|
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2017 |
4
| Malley Thomas (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 169,988 options to buy
@ $0 |
|
| 04/04/2017 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc. |
| 01/04/2017 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc. |
| 11/28/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on BeiGene, Ltd. |
| 10/04/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc. |
| 07/05/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc.|
Txns:
| Granted 2,543 shares
@ $0 |
|
| 06/06/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc.|
Txns:
| Granted 12,000 options to buy
@ $7.38, valued at
$88.6k
|
|
| 06/03/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc.|
Txns:
| Granted 50,000 shares
@ $7, valued at
$350k
|
|
| 05/13/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.12, valued at
$31.2k
Granted 10,000 options to buy
@ $3.12, valued at
$31.2k
|
|
| 04/04/2016 |
4
| Malley Thomas (Director) has filed a Form 4 on OvaScience, Inc.|
Txns:
| Granted 1,396 shares
@ $0 |
|
| 01/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/17/2015 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Bought 50,000 shares
@ $8, valued at
$400k
|
|
| 10/14/2015 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 30,000 options to buy
@ $14, valued at
$420k
|
|
|